Pacer Advisors’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,028
| Closed | -$9.15K | – | 2683 |
|
|
2024
Q2 | $9.15K | Sell |
1,028
-1,175
| -53% | -$10.5K | ﹤0.01% | 3541 |
|
|
2024
Q1 | $22.3K | Buy |
2,203
+2,044
| +1,286% | +$20.7K | ﹤0.01% | 3424 |
|
|
2023
Q4 | $1.6K | Sell |
159
-39
| -20% | -$392 | ﹤0.01% | 3486 |
|
|
2023
Q3 | $1.86K | Hold |
198
| – | – | ﹤0.01% | 2607 |
|
|
2023
Q2 | $4.86K | Buy |
198
+28
| +16% | +$687 | ﹤0.01% | 3446 |
|
|
2023
Q1 | $3.96K | Sell |
170
-1,099,224
| -100% | -$25.6M | ﹤0.01% | 2079 |
|
|
2022
Q4 | $27.8M | Buy |
1,099,394
+1,099,190
| +538,819% | +$27.8M | 0.14% | 117 |
|
|
2022
Q3 | $4K | Sell |
204
-784,207
| -100% | -$15.4M | ﹤0.01% | 2060 |
|
|
2022
Q2 | $20M | Buy |
784,411
+784,139
| +288,286% | +$20M | 0.15% | 117 |
|
|
2022
Q1 | $7K | Sell |
272
-67
| -20% | -$1.72K | ﹤0.01% | 2257 |
|
|
2021
Q4 | $14K | Buy |
339
+157
| +86% | +$6.48K | ﹤0.01% | 2173 |
|
|
2021
Q3 | $8K | Hold |
182
| – | – | ﹤0.01% | 1403 |
|
|
2021
Q2 | $9K | Sell |
182
-1,557
| -90% | -$77K | ﹤0.01% | 1385 |
|
|
2021
Q1 | $89K | Sell |
1,739
-2,639
| -60% | -$135K | ﹤0.01% | 1308 |
|
|
2020
Q4 | $117K | Buy |
4,378
+4,206
| +2,445% | +$112K | ﹤0.01% | 1342 |
|
|
2020
Q3 | $6K | Buy |
172
+86
| +100% | +$3K | ﹤0.01% | 1377 |
|
|
2020
Q2 | $4K | Buy |
+86
| New | +$4K | ﹤0.01% | 931 |
|